Darling Ingredients Inc. <DAR.N>: UBS raises target price to $88 from $78
DAR•Related News
Amgen says Phase 3 OASIZ 301 trial meets primary endpoint for dazodalibep in systemic Sjögren's disease
AMGN•
BUZZ-U.S. Stocks on the Move-Vicor, Thor Industries, Lennar
SPY•
JX Luxventure raises 2026 equity incentive plan share reserve to 9,300,000 from 4,500,000
JXG•
Compass Therapeutics Provides Regulatory Update On Tovecimig In Biliary Tract Cancer Following FDA Feedback
CMPX•
U.S. Research Roundup-Boeing, Twilio, W.P. Carey
BA•